| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","company":"SOPHiA GENETICS SA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","article_chars":2685,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_bc1c1278714c0142","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","content_type":"text/plain","enriched_at":"2026-04-09T17:45:27.884007+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt","source_event_id":"evt_c2fad4010be9","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"f9950bbdeed07715","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-02","2026-04-03","2026-04-06","2026-04-07","2026-04-08","2026-04-09"],"entities":[{"asset_class":"equity","name":"SOPHiA GENETICS SA","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Xu Zhenyu","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Elimara Brunetto","relevance":"low","symbol":"","type":"attorney_in_fact"}],"event_type":"listing","information_gaps":["The text provided does not include the prior known state to compare what changed (delta vs earlier filings).","The filing type is clear (Form 4), but the specific number of total shares sold across all transactions is not fully enumerated beyond the two visible lines (2700 and 2400).","No explicit post-transaction holdings are shown in the provided excerpt, so changes to remaining ownership cannot be quantified from this text alone."],"key_facts":["SEC filing: Form 4 (conformed submission type: 4).","Issuer: SOPHiA GENETICS SA (CIK: 0001840706).","Reporting person: Xu Zhenyu (CIK: 0002006362).","Filing accession number: 0001840706-26-000121.","Conformed period of report: 20260406; filed as of date: 20260408; date as of change: 20260408.","The filing includes sales of ordinary shares by the reporting person in the open market.","Stated purpose: shares sold to satisfy tax withholding obligations arising from vesting of restricted stock units on April 2 and 3, 2026.","Execution method: sales were effected pursuant to a pre-established Rule 10b5-1 trading plan and are stated not to represent discretionary trades.","The price in Column 4 is a weighted average price.","Shares were sold in multiple transactions at prices ranging from $4.67 to $4.95 (inclusive) (one footnote range).","The filing also includes a second stated price range from $4.69 to $4.98 (inclusive) (another footnote range).","The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the stated range upon written request."],"numeric_claims":[{"label":"Weighted average price (Column 4)","value":"4.852"},{"label":"Shares sold (first reported line)","value":"2700"},{"label":"Weighted average price (Column 4)","value":"4.8663"},{"label":"Shares sold (second reported line)","value":"2400"},{"label":"Price range (inclusive)","value":"$4.67 to $4.95"},{"label":"Price range (inclusive)","value":"$4.69 to $4.98"}],"primary_claim":"On 2026-04-06 (period of report) and filed on 2026-04-08, reporting person Xu Zhenyu sold SOPHiA GENETICS SA ordinary shares in open-market transactions to satisfy tax withholding obligations tied to RSU vesting, under a Rule 10b5-1 trading plan.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"SOPHiA GENETICS SA filed a Form 4 on 2026-04-08 reporting sales of ordinary shares by reporting person Xu Zhenyu. The filing states the sales were made to satisfy tax withholding obligations related to vesting of restricted stock units and were executed under a Rule 10b5-1 trading plan.","topics":["SEC Form 4","insider trading","Rule 10b5-1 plan","tax withholding","restricted stock units (RSUs)","ordinary shares sales"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 SOPHiA GENETICS SA \u00b7 Filed 20260408","ticker":"SOPH","tickers":["SOPH"],"title":"SOPH filed 4","url":"https://www.sec.gov/Archives/edgar/data/1840706/0001840706-26-000121.txt"}... |